Register Now - Beyond Recruitment: The Future of Patient Site Engagement in Oncology Clinical Trials
|Articles|November 1, 2008

Applied Clinical Trials

  • Applied Clinical Trials-11-01-2008
  • Volume 0
  • Issue 0

eClinical Software: November 2008

Author(s)Kerri Nelen

The latest eClinical software in the clinical trials industry.

Send your new product info to: Kerri Nelen, knelen@advanstar.com

Enterprise Document Management for the Lab

Collaborative agreement calls for product bundle for laboratories

NextDocs integrated document solution

Thermo Fisher Scientific (Woburn, MA) and NextDocs (King of Prussia, PA) have entered into an agreement whereby NextDocs Document and Compliance Suite will offer an extension of Thermo Fisher Scientific's laboratory information management systems (LIMS) and chromatography data systems (CDS) products.

The product will be sold by Thermo Fisher Scientific under the NextDocs name and will offer fully integrated informatics and a content management solution that complies with FDA 21 CFR Part 11, GMP, GLP, GCP, and other regulation and industry standards.

The NextDocs suite is built on the Microsoft SharePoint 2007 platform.

Thermo Fisher Scientific, (781) 933 4689, www.thermo.com/informatics

Product Registration and Labeling Integrated

Solution addresses life sciences end-to-end global product tracking

Aris Global (Stamford, CT) and i4i (Toronto) have integrated their products: ALiCE 4 Labeling (A4L) from i4i and Aris Global's Register.

Aris Global and i4i joint product manager

A4L is an XML-based product label and authoring application, while the Register solution offers a central repository for managing the end-to-end tracking of global product registration details and submissions. The integrated applications will provide a comprehensive solution for centrally managing products, tracking and planning global registrations, and addressing all authoring and lifecycle management aspects of e-label production.

The joint solution enables organizations to manage and track updates and variations to determine any regulatory impact of proposed changes.

Aris Global, (203) 588-3000, www.arisglobal.com

Send your new product info to: Kerri Nelen, knelen@advanstar.com

Metadata Management Added to Suite

Module targets data management and transfer for teams

Image Solutions, Inc (ISI) (Whippany, NJ) announced its new module—ISI Submission Manager (ISM)—to its integrated regulatory solution suite. The module targets metadata and the relationship between submissions and allows regulatory teams to manage and transfer data between submissions, as well as create reports based on submission status from eCTDXPress and ISIPublisher, ISI's products that manage eCTD, paper, and non-eCTD electronic submissions. The suite is now integrated on a single platform.

Image Solution ISI Submission Manager

There are two key components to ISM. The first allows users to access outline views for all of the eCTDXPress applications/submissions. The second component, Metadata View, allows users to view hierarchy, Regional, ICH, STF, and custom metadata associated with each publication or submission.

ISI, (973) 560-0404, www.imagesolutions.com

Send your new product info to: Kerri Nelen, knelen@advanstar.com

Articles in this issue

about 18 years ago

Europe Reviews Balance of Interests

about 18 years ago

Work-Life Notes from a Large CRO

about 18 years ago

Work-Life Notes from a Small CRO

about 18 years ago

Welcome to the 21st Century

about 18 years ago

Foundation Tackles CNS Trials

about 18 years ago

The Changing Role of CRAs

about 18 years ago

A Global Regulatory GPS?

Related to this article

Closing the Community Access Gap: Q&A with Kent Thoelke, Paradigm Health
In this Q&A, Kent Thoelke, CEO of Paradigm Health, discusses why participation gaps in community and rural settings come down to both patient cost barriers and site infrastructure, how legacy workflows weigh on community clinics, and what policy and technology changes it would take to make clinical research a real care option for more patients.
© Grispb - © Grispb - stock.adobe.com
Mistral and OpenAI produced identical overall eligibility labels across 200 synthetic patient-study assessments, with criterion-level disagreements concentrated in inclusion criteria where models switch between “Uncertain” and “Not included” when records lack sufficient evidence, so model choice should be driven by deployment architecture, control, and cost rather than assumed interchangeability.
The Human Side of Clinical Trials: Before Burden Becomes Risk, Capturing Friction in Real Time
In Episode 4 of The Human Side of Clinical Trials, host Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., speaks with Jason Riis, PhD, CEO and chief behavioral scientist at Behavioralize, about how capturing friction closer to the moment it happens can reveal unclear instructions, technology friction, and workarounds that retrospective surveys and debriefs tend to miss.